CareView Communications Inc 8-K

What Happened
CareView Communications, Inc. filed a Form 8-K (filed July 2, 2026) disclosing a Fifteenth Amendment to its Credit Agreement dated June 30, 2026. The amendment, entered into with PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), extends the Credit Agreement’s maturity date to September 30, 2026. CEO Steven G. Johnson and director Dr. James R. Higgins are signatories to the amendment. The amendment is attached as Exhibit 10.47 to the 8-K.

Key Details

• Amendment date / filing: amendment entered June 30, 2026; Form 8-K filed July 2, 2026.
• New Maturity Date: extended to September 30, 2026.
• Parties: Borrower — CareView Communications, Inc.; Lender/Agent — PDL Investment Holdings, LLC (assignee of PDL BioPharma, Inc.).
• Reported as a material agreement (Item 1.01) and as a creation/modification of a direct financial obligation (Item 2.03); amendment included as Exhibit 10.47.

Why It Matters
This amendment changes CareView’s debt timeline by pushing the loan repayment date into late Q3 2026, which is material to the company’s near-term liquidity and financing plan. Investors should note the company’s continued reliance on amendments to its credit arrangements (the original Credit Agreement dates to 2015 and has been amended repeatedly) and may monitor for further amendments, refinancing, or other actions affecting cash flow and debt obligations. The full amendment is available in Exhibit 10.47 of the filing for details.